product summary
Loading...
company name :
MyBioSource
product type :
antibody
product name :
Polyclonal Antibody to FMS Like Tyrosine Kinase 3 (Flt3)
catalog :
MBS2026193
quantity :
0.01 mg
price :
105 USD
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation
more info or order :
image
image 1 :
MyBioSource MBS2026193 image 1
Western Blot: Sample: Lane1: Human K562 Cells; Lane2: Human HepG2 Cells.
image 2 :
MyBioSource MBS2026193 image 2
Western Blot: Sample: Recombinant Flt3, Mouse.
image 3 :
MyBioSource MBS2026193 image 3
DAB staining on IHC-P; Samples: Mouse Testis Tissue.
product information
catalog number :
MBS2026193
products type :
Antibody
products full name :
Polyclonal Antibody to FMS Like Tyrosine Kinase 3 (Flt3)
products short name :
[FMS Like Tyrosine Kinase 3]
other names :
[receptor-type tyrosine-protein kinase FLT3; Receptor-type tyrosine-protein kinase FLT3; receptor-type tyrosine-protein kinase FLT3; FMS-like tyrosine kinase 3; FL cytokine receptor; Fetal liver kinase 2; FLK-2; Fms-like tyrosine kinase 3; FLT-3; Tyrosine-protein kinase receptor flk-2; CD_antigen: CD135]
products gene name :
[Flt3]
other gene names :
[Flt3; Flt3; Flk2; Ly72; wmfl; CD135; Flk-2; Flt-3; B230315G04; Flk-2; Flt-3; FLK-2; FLT-3]
clonality :
Polyclonal
isotype :
IgG
host :
Rabbit
reactivity :
Mouse
specificity :
The antibody is a Rabbit polyclonal antibody raised against Flt3. It has been selected for its ability to recognize Flt3 in immunohistochemical staining and western blotting.
purity :
Antigen-specific Affinity Chromatography
form :
Supplied as solution form in 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
concentration :
200ug/ml
storage stability :
Storage: Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
tested application :
WB; IHC; ICC; IP
app notes :
Western blotting: 0.5-5µg/mL. Immunohistochemistry: 5-20µg/mL. Immunocytochemistry: 5-20µg/mL. Optimal working dilutions must be determined by end user
image1 heading :
Western Blot (WB)
image2 heading :
Western Blot (WB)
image3 heading :
Immunohistochemistry (IHC)
image4 heading :
Immunohistochemistry (IHC)
image4 description :
DAB staining on IHC-P; Samples: Mouse Kidney Tissue
image5 heading :
Immunohistochemistry (IHC)
image5 description :
DAB staining on IHC-P; Samples: Mouse Skeletal Muscle Tissue.
other info1 :
Source: Polyclonal antibody preparation. Traits: Liquid. Immunogen: Recombinant Flt3 (Lys335~Ser544) expressed in E.coli
other info2 :
Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2035733
ncbi gi num :
122937353
ncbi acc num :
NP_034359.2
ncbi gb acc num :
NM_010229.2
uniprot acc num :
Q00342
ncbi mol weight :
113,496 Da
ncbi pathways :
Acute Myeloid Leukemia Pathway (83310); Acute Myeloid Leukemia Pathway (529); Cytokine-cytokine Receptor Interaction Pathway (83248); Cytokine-cytokine Receptor Interaction Pathway (460); Hematopoietic Cell Lineage Pathway (83275); Hematopoietic Cell Lineage Pathway (489); Pathways In Cancer (83298); Transcriptional Misregulation In Cancer Pathway (523020); Transcriptional Misregulation In Cancer Pathway (522987)
uniprot summary :
FLT3: a receptor tyrosine kinase of the PDGFR family that binds the FL cytokine. FLT3 -/- mice have an impaired developmental capacity of primitive hematopoietic progenitor cells of all lineages with the greatest impact on lymphopoietic precursors. Activating mutations found in one third of cases of acute myeloid leukemia (AML), as well as in acute lymphoblastic leukemia, acute promyelocytic leukemia and myelodysplastic syndrome. Inhibitors: Sutent and PKC412. Protein type: EC 2.7.10.1; Kinase, protein; Membrane protein, integral; Oncoprotein; PDGFR family; Protein kinase, TK; Protein kinase, tyrosine (receptor); TK group. Chromosomal Location of Human Ortholog: 5 86.88 cM 5 G3. Cellular Component: cell surface; cytoplasm; cytosol; endoplasmic reticulum; external side of plasma membrane; integral component of membrane; membrane; nucleus; plasma membrane; protein complex. Molecular Function: ATP binding; glucocorticoid receptor binding; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; kinase activity; nucleotide binding; phosphoinositide 3-kinase binding; protein binding; protein complex binding; protein kinase activity; protein self-association; protein tyrosine kinase activity; transferase activity; transmembrane receptor protein tyrosine kinase activity; ubiquitin protein ligase binding. Biological Process: antigen processing and presentation; B cell differentiation; cell differentiation; cellular response to cytokine stimulus; cytokine-mediated signaling pathway; hemopoiesis; homeostasis of number of cells within a tissue; leukocyte homeostasis; lymph node development; lymphocyte differentiation; lymphocyte proliferation; lymphoid progenitor cell differentiation; myeloid progenitor cell differentiation; negative regulation of B cell differentiation; negative regulation of cell proliferation; negative regulation of interleukin-6 production; negative regulation of tumor necrosis factor production; phosphorylation; positive regulation of interferon-alpha production; positive regulation of interferon-alpha secretion; positive regulation of interferon-gamma production; positive regulation of interferon-gamma secretion; positive regulation of interleukin-12 production; positive regulation of interleukin-12 secretion; positive regulation of multicellular organism growth; positive regulation of protein phosphorylation; post-embryonic development; pro-B cell differentiation; pro-T cell differentiation; protein amino acid phosphorylation; protein autophosphorylation; spleen development; transmembrane receptor protein tyrosine kinase signaling pathway
size1 :
0.01 mg
price1 :
105 USD
size2 :
0.02 mg
price2 :
125
size3 :
0.05 mg
price3 :
170
size4 :
0.1 mg
price4 :
210
size5 :
0.2 mg
price5 :
315
size6 :
1 mg
price6 :
745
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!